Nav: Home

Physician adherence to clinical decision tools suggests potential benefit to PE patients

March 23, 2017

Leesburg, VA, March 22, 2017-- A review paper published in the American Journal of Roentgenology (AJR) suggests a potential benefit to the use of clinical decision tools in the diagnostic work-up of suspected pulmonary embolism (PE) patients. The finding could impact the traditional use of pulmonary CT angiography (CTA) as the imaging modality of choice for evaluating patients believed to suffer from PE.

The study titled "Role of Clinical Decision Tools in the Diagnosis of Pulmonary Embolism" indicates that despite the increased use of pulmonary CTA, the diagnostic yield remains low. Dr. William M. Sherk and Dr. Jadranka Stojanovska, both from University of Michigan Health Systems, Ann Arbor, authored the paper which is available for viewing on the AJR website accessible here.

"While pulmonary CTA is desirable as a test for suspected PE, the binary yes or no answer to a challenging diagnosis with ambiguous clinical presentation is enticing," said Stojanovska. "As with other diagnostic tests, however, the posttest probability of pulmonary CTA hinges on pretest clinical assessment."

"Validated clinical decision rules and integrated clinical decision support (CDS) systems can influence the appropriate use of pulmonary CTA, but further investigation is required to define the most successful means of integration into clinical practice," Stojanovska said.

PE is a frequently suspected diagnosis, especially in patients appearing in emergency departments with cardiopulmonary symptoms. The study suggests that CTA is overused as a screening rather than a diagnostic examination, which increases financial costs and medical consequences from radiation exposure and the use of contrast media.

Clinical decision rules were developed to determine which patients would benefit from further diagnostic work-up such as pulmonary CTA. Unfortunately, according to the study, the moderate impact of CDS on pulmonary CTA use and yield is related to physician nonadherence, an issue that is not unique.

Electronic clinical decision rules or support systems are cumbersome and require added input by the ordering clinician. Distrust of standardized rules, fear of legal retribution if a morbid or fatal PE is missed, and unfamiliarity with radiation exposure and iodinated contrast risks all further detract from successful implementation. Patient input also factors into nonadherence; some patients with particular symptoms may request CT for evaluation. Clinicians may assume that in the absence of PE an alternative diagnosis will be established with pulmonary CTA, despite evidence that different etiologic factors are supported in only one-third of cases.

According to the study, single or limited educational intervention is not as likely to help overcome these obstacles as repetitive educational efforts up to five years.
-end-
Founded in 1900, ARRS is the first and oldest radiology society in the United States, and is an international forum for progress in radiology. The Society's mission is to improve health through a community committed to advancing knowledge and skills in radiology. ARRS achieves its mission through an annual scientific and educational meeting, publication of the American Journal of Roentgenology (AJR) and InPractice magazine, topical symposia and webinars, and print and online educational materials. ARRS is located in Leesburg, VA.

American Roentgen Ray Society

Related Pulmonary Embolism Articles:

Short or long sleep associated with Pulmonary Fibrosis
Scientists have discovered that people who regularly sleep for more than 11 hours or less than 4 hours are 2-3 times more likely to have the incurable disease, pulmonary fibrosis, compared to those that sleep for 7 hours in a day.
Better way to interpret blood tests to diagnose pulmonary embolism
A study led by Hamilton researchers has found a new way to interpret blood test results in patients who are investigated for blood clots in their lungs, a condition known as pulmonary embolism.
Reversed halo signs manifest in septic pulmonary embolism due to IV drug use
According to an article published ahead-of-print in the January 2020 issue of the American Journal of Roentgenology (AJR), reversed halo signs were frequently observed on the chest CT scans of patients with IV substance use disorder-related septic pulmonary embolism.
Treating pulmonary embolism: How safe and effective are new devices?
A new scientific statement from the American Heart Association identifies the risks and benefits of novel interventional devices compared to anticoagulation alone in the treatment of patients with pulmonary embolism.
Promising steps towards a treatment for pulmonary fibrosis
Research published in the journal Science Translational Medicine on 25 September by members of the Cardiovascular Disease Mechanisms group at the MRC LMS in collaboration with Duke-NUS Medical School, National Heart Centre Singapore & National Heart and Lung Institute, Imperial College London, showed that blocking a protein called interleukin-11 (IL-11) using therapeutic antibodies can reverse the fibrosis in the lung.
African-Americans with COPD appear less likely to use pulmonary rehab
African-American patients with chronic obstructive pulmonary disease, or COPD, are less likely to participate in pulmonary rehabilitation programs than white patients, even when there are programs nearby.
Lung-on-a-chip simulates pulmonary fibrosis
New biotechnology reported in the journal Nature Communications could make testing potential medicine for pulmonary fibrosis, one of the most common and serious forms of lung disease, quicker and less expensive.
Study identifies new target for treatment of pulmonary hypertension
Inhibiting FoxM1 gene reverses disease process in animal models of pulmonary hypertension.
Pulmonary fibrosis caused by single transcription factor
Reduced FoxO3 activity reprograms connective tissue cells, triggering the disease.
Lung cancer triggers pulmonary hypertension
Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension.
More Pulmonary Embolism News and Pulmonary Embolism Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.